Case · Lillebaelt Hospital Vejle
More patients get better treatment with fewer resources
To treat more patients with the same resources and improve the quality of care, the Region of Southern Denmark implemented CSO/Anticoagulation from IntraMed.
Case · Lillebaelt Hospital Vejle
“Many doctors worry about putting patients on anticoagulation therapy. But it is far more dangerous to leave the patient untreated. With CSO/Anticoagulation we are able to prevent at least 100 cerebral thromboembolic episodes per year in the Region of Southern Denmark.”
“In Vejle we carry out 10,000 outpatient checks a year. The Danish DRG system is based on average treatment costs and rewards efficiency. That is why we achieve better treatment of anticoagulation patients, while CSO/Anticoagulation helps us reduce our use of resources.”
Ivan BrandslundMD, DMSc, Head of Research and Professor, Lillebaelt Hospital
Results
From 15 to around 2,500 self-testing patients
The Region of Southern Denmark implemented CSO/Anticoagulation after a successful pilot with 15 patients in a self-monitoring programme. The patients measured their own INR at home and registered the value in the web-based system.
Today, the number of self-testing patients has grown to around 2,500. When patients measure themselves, outpatient resources can be used for other patients, and clinicians can focus on high-risk patients or patients with complications.
About Vejle Hospital
Vejle Hospital is part of the Region of Southern Denmark. The hospital employs around 2,200 staff and treats about 22,000 inpatients and around 150,000 outpatients.
Want the same results?
We are happy to tell you more about CSO / Anticoagulation.